Skip to content

Pharmacy

PSG releases trends in specialty drug benefits report

PSG releases trends in specialty drug benefits report

DALLAS – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering visibility into the complexity of the specialty drug landscape, it offers detailed intelligence through proprietary research.

PSG releases trends in specialty drug benefits report

PSG releases trends in specialty drug benefits report

DALLAS – Pharmaceutical Strategies Group (PSG), an EPIC company, is pleased to announce the release of its annual Trends in Specialty Drug Benefits report. Delivering visibility into the complexity of the specialty drug landscape, it offers detailed intelligence through proprietary research.

Amazon announces first quarter results

Amazon announces first quarter results

Amazon on April 27 posted a profit of $3.2 billion for the first quarter, up from a loss of $3.8 billion in the year-ago quarter and easily surpassing analysts’ estimates. The swing to a profit came as Amazon ramped up cost-cutting measures.

Amazon announces first quarter results

Amazon announces first quarter results

Amazon on April 27 posted a profit of $3.2 billion for the first quarter, up from a loss of $3.8 billion in the year-ago quarter and easily surpassing analysts’ estimates. The swing to a profit came as Amazon ramped up cost-cutting measures.

NACDS honors John Standley at Annual Meeting

NACDS honors John Standley at Annual Meeting

PALM BEACH, Fla. – The National Association of Chain Drug Stores (NACDS) has recognized NACDS Past Chair John Standley with chain pharmacy’s highest honor: the Sheldon W. Fantle Lifetime Achievement Award. From 2020-2022, Standley served as president of Walgreens.

Camber launches generic Zyflo

Camber launches generic Zyflo

PISCATAWAY, N.J.– Camber Pharmaceuticals is pleased to announce the addition of zileuton ER tablets to its current portfolio. Zileuton ER tablets are indicated for the prophylaxis and chronic treatment of asthma in adults and children 12 years of age and older.